Deccan Chronicle

Haffkine targets 22.8 cr vax vials


Mumbai, April 16: After receiving permission to make Bharat Biotech’s Covid-19 vaccine Covaxin, Mumbai-based Haffkine BioPharmac­eutical on Friday said it would take least at one year’s time for the company to start actual production.

A top official said the state-run company is targeting to produce 22.8 crore vials of the vaccine per year.

Speaking to reporters here, Dr Sandeep Rathod, managing director, Haffkine BioPharmac­eutical Corporatio­n Ltd, said, Our target is to produce around 22.8 crore vaccine vials but it will take one year for us to start production. Hyderabad-based Bharat Biotech and the ICMR have developed Covaxin, one of the two vaccines being used in the ongoing nationwide vaccinatio­n drive. “And now we received a contract to produce the vaccine at our Parel facility in Mumbai,” he said.

“A proposal was submitted in January owing to the rising cases of coronaviru­s and need for more vaccines to immunise a large number of people. It is an ambitious project which is important from the angle of vaccinatio­n of such a large population, said the managing director of the Maharashtr­a government undertakin­g.

Newspapers in English

Newspapers from India